Harold Shlevin Email & Phone Number
@galectintherapeutics.com
4 phones found area 678 and 617
LinkedIn matched
Who is Harold Shlevin? Overview
A concise factual answer block for searchers comparing this professional profile.
Harold Shlevin is listed as Principal at dba Chana Tikvah Pharma Partners, based in Boynton Beach, Florida, United States. AeroLeads shows a work email signal at galectintherapeutics.com, phone signal with area code 678, 617, and a matched LinkedIn profile for Harold Shlevin.
Harold Shlevin previously worked as Director Board Of Directors at Galectin Therapeutics and Authorized Agent for Galectin Therapeutics Inc at Galectin Therapeutics. Harold Shlevin holds Post Doctoral, Physiology And Pharmacology from Mayo Clinic Alix School Of Medicine.
Email format at dba Chana Tikvah Pharma Partners
This section adds company-level context without repeating Harold Shlevin's masked contact details.
AeroLeads found 2 current-domain work email signals for Harold Shlevin. Compare company email patterns before reaching out.
About Harold Shlevin
An accomplished leader in small, medium & large pharma and device companies with a track-record of attracting capital, competing successfully to negotiate partnering, commercializing new products, turning around operations, outsourcing, scaling-up solid leadership teams, optimizing regulatory compliance, and aligning diverse functions in global alliances and corporate structures. Also experienced on public and private company Board of Directors roles. He currently provides consulting services to small and mid-size pharma and biopharma companies..He retired, in September 2020, from the CEO and President role at Galectin Therapeutics Inc (NASDAQ:GALT) a clinical stage pharmaceutical company focused on liver fibrosis and cancer which he joined in 2012 as COO and was most recently CEO . He remains on Galectin Therapeutics board of directors. In prior roles, he led Georgia Institute of Technology’s ATDC as Principal in bio-science commercialization efforts where he helped to found Clearside Biomedical. Previously, he was Head of Operations & Commercial Development for Altea Therapeutics Corp. .From 2006-2008, Dr. Shlevin was a founder and CEO of Tikvah Therapeutics, focused on late-stage development of therapeutics & devices for treatment of neurological diseases. From 1998 – 2006, he held position of increasing responsibility at Solvay Pharmaceuticals including that of President and CEO of its US organization . Under Dr. Shlevin’ leadership, Solvay Pharma US . experienced record growth in revenue & profits; He managed resolution of a long-standing adverse regulatory matter without fines or consent decrees.He held senior executive positions at Bausch & Lomb Pharmaceuticals, CIBA Vision Opthalmics (co-founder), CIBA-Geigy Pharmaceuticals, and Searle Pharmaceuticals..Dr Shlevin earned a PhD in physiology from the U.of Rochester and post-doctoral at Mayo Clinic where he served as Asst Prof. of Pharmacology & Physiology. He served on the Board of Directors of Cardiome Pharma Corp. and as a Board advisor to Clearside BiomedicalSpecialties: General Management, Business Development, Licensing, Mergers and Acquisitions, R&D including product development and registration, Regulatory, Commercial,and Strategic Planning
Harold Shlevin's current company
Company context helps verify the profile and gives searchers a useful next step.
Harold Shlevin work experience
A career timeline built from the work history available for this profile.
Director Board Of Directors
Current
Authorized Agent For Galectin Therapeutics Inc
Consultant to Galectin Therapeutics reporting to the new CEO. Assist in smooth CEO transition, handle various aspects of the adaptively designed Phase 2/3 trial in NASH cirrhosis and various other business related activities
Chief Executive Officer And President
Retired Sept 2, 2020 and working for Galectin Therapeutics as Authorized Agent (consultant) for the company
Chief Operating Officer
Galectin Therapeutics is a clinical-stage biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and.
Board Advisor
CurrentPrincipal
CurrentStrategic consultant to Pharma and Biotech industries
Principal And Ceo
Current- Strategic Consulting, including business plan & sales strategy development. Pharmaceuticals, Medical Devices, Vaccines and DiagnosticsSpecific Expertise in Product Development, Regulatory and Commercial
Board Of Directors
NASDAQ: CRME; See Cardiome Pharma website at www.cardiome.com for further informationChairman of the Compensation Committee; past member of the Audit Committee and the Corporate Governance Committee
Board Of Directors
NeurOp, Inc. is a preclinical-stage biopharmaceutical company developing new medicines to treat central nervous system disorders, including major depression, neuropathic pain and ischemia. Neurop's mission is to develop a new generation of N-methyl-D-aspartate (NMDA) receptor blockers, which inhibit proteins that play an important role in neuron signaling..
Executive In Residence, Commercializaton Catalyst And Head Atdc - Biosciences
Basic responsibilities of this faculty rank position include: - Serving as Executive-in-Residence - Coaching and mentoring of bioscience companies - Developing and managing various entrepreneurial programs to accelerate the growth of technology start-up companies - especially in biosciences - Interfacing closely with faculty to maintain awareness of all.
Vp Head Of Operations & Commercial Development
Responsible for Pharmaceutical Sciences (formulation, analytical, process development, QC, clinical supplies), Engineering Sciences (electrical/mechanical engineering & applicator manufacturing), Commercial Development, QA, Clinical research, Regulatory affairs, Finance
President & Ceo, And Founder
Tikvah Therapeutics is a development stage pharmaceutical company focused on neurosciences.
President And Chief Executive Officer
CEO Solvay Pharmaceuticals, USA Operations; Responsible for all US operations from R&D through commercial; full P&L responsibility; Member of global pharmaceuticals management committee. Achieved record levels of revenues and profits through aggressive business development, r&d focus, strategic realignment of internal functions.Board of Directors Solvay.
Sr Vp Business Development & Research & Development
Head of US Business Development responsible for in/out licensing, acquisitions; member of global business development team and research & development management team.Head of R&D responsible for preclinical through market approval of pharmaceutical productsPromoted to CEO Solvay Pharmaceuticals USA - May 2000
Global Sr Vp - Resqs
Global Sr VP and member of the Board of Directors of Solvay Pharmaceuticals, SA - the global management organization of Solvay's worldwide pharmaceutical businesses.
Vp Technical Affairs And Business Development And A Founder
Co-Founder of CIBA Vision Ophthalmics and member of the management team which started and grew the opthalmic pharmaceutical business for CIBA-Geigy Pharmaceuticals.Led New Business Development and R&D efforts in specialty pharmaceuticals.including partnering and acquisitions. Gained approval of several new ophthalmic drugs
Svp - R&D
Bausch & Lomb Pharmaceuticals is the pharmaceutical business of Bausch and Lomb. Products included ophthalmic pharmaceuticals.
Various
Executive Level - Strategic and Business Planning, R&D Management, IT Management, General Business Management
Senior Scientist
Senior scientist role responsible for establishment of drug discovery in the general area of cardiovascular with specialty in antiarrhythmic drug design and discovery.
Harold Shlevin education
Post Doctoral, Physiology And Pharmacology
Phd, Physiology
Bs, Biology
Frequently asked questions about Harold Shlevin
Quick answers generated from the profile data available on this page.
What company does Harold Shlevin work for?
Harold Shlevin works for dba Chana Tikvah Pharma Partners.
What is Harold Shlevin's role at dba Chana Tikvah Pharma Partners?
Harold Shlevin is listed as Principal at dba Chana Tikvah Pharma Partners.
What is Harold Shlevin's email address?
AeroLeads has found 2 work email signals at @galectintherapeutics.com for Harold Shlevin at dba Chana Tikvah Pharma Partners.
What is Harold Shlevin's phone number?
AeroLeads has found 4 phone signal(s) with area code 678, 617 for Harold Shlevin at dba Chana Tikvah Pharma Partners.
Where is Harold Shlevin based?
Harold Shlevin is based in Boynton Beach, Florida, United States while working with dba Chana Tikvah Pharma Partners.
What companies has Harold Shlevin worked for?
Harold Shlevin has worked for Dba Chana Tikvah Pharma Partners, Galectin Therapeutics, Moonlight Therapeutics, Chana Tikvah Pharma Consulting Partners, and Cardiome Pharma Corp.
How can I contact Harold Shlevin?
You can use AeroLeads to view verified contact signals for Harold Shlevin at dba Chana Tikvah Pharma Partners, including work email, phone, and LinkedIn data when available.
What schools did Harold Shlevin attend?
Harold Shlevin holds Post Doctoral, Physiology And Pharmacology from Mayo Clinic Alix School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial